Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy

BACKGROUND: The aim of this study was to investigate the predictive and prognostic values of intratumoural human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase subunit 1 (RRM1) expression in advanced cholangiocarcinoma patients treated with adjuvant gemcitabine-based che...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sasaki, H, Murakami, Y, Uemura, K, Sudo, T, Hashimoto, Y, Kondo, N, Sueda, T
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4183840/
https://ncbi.nlm.nih.gov/pubmed/25032731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.399
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky